A systematic review to investigate whether Angiotensin-(1-7) is a promising therapeutic target in human heart failure

International Journal of Peptides

Volumn 2013, Issue , 2013, Pages

  Lee, Vincent C H ^a   Lloyd, Elizabeth N ^a   Dearden, Helena C ^a   Wong, Kenneth ^a  

^a CASTLE HILL HOSPITAL   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 84893758411     PISSN: 16879767     EISSN: 16879775     Source Type: Journal    
DOI: 10.1155/2013/260346     Document Type: Review

References (81)

1. Lloyd-Jones D., Adams R. J., Brown T. M., Carnethon M., Dai S., De Simone G., Ferguson T. B., Ford E., Furie K., Gillespie C., Go A., Greenlund K., Haase N., Hailpern S., Ho P. M., Howard V., Kissela B., Kittner S., Lackland D., Lisabeth L., Marelli A., McDermott M. M., Meigs J., Mozaffarian D., Mussolino M., Nichol G., Roger V. L., Rosamond W., Sacco R., Sorlie P., Stafford R., Thom T., Wasserthiel-Smoller S., Wong N. D., Wylie-Rosett J., Executive summary: heart disease and stroke statistics-2010 update: a report from the american heart association. Circulation 2010 121 7 e46 e215 2-s2.0-77649126524 10.1161/CIRCULATIONAHA.109.192667
2. Dallas T. X., American Heart Association, Heart Disease and Stroke Statistics 2008 Update 2008 Chicago, Ill, USA American Heart Association
3. McCullough P. A., Philbin E. F., Spertus J. A., Kaatz S., Sandberg K. R., Weaver W. D., Confirmation of a heart failure epidemic: findings from the resource utilization among congestive heart failure (REACH) study. Journal of the American College of Cardiology (Pubitemid 34059862)
4. Croft J. B., Giles W. H., Pollard R. A., Keenan N. L., Casper M. L., Anda R. F., Heart failure survival among older adults in the United States: a poor prognosis for an emerging epidemic in the Medicare population. Archives of Internal Medicine 1999 159 5 505 510 2-s2.0-0033535360 10.1001/archinte.159.5. 505 (Pubitemid 29108917)
5. Centers for Medicare, Medicaid Services, Health Care Financing Review: Medicare and Medicaid Statistical Supplement 2005 Baltimore, Md, USA Centers for Medicare and Medicaid Services Table 5. 5: Discharges, Total Days of Care, and Program Payments for Medicare Beneficiaries Discharged from Short-Stay Hospitals, by Principal Diagnoses Within Major Diagnostic Classifications (MDCs): Calendar Year 2006. http://www.cms.hhs.gov/MedicareMedicaid StatSupp/
6. Levy D., Kenchaiah S., Glarson M., Benjamin E. J., J.kupka M., Ho K. K. L., Murabito J. M., Vasan R. S., Long-term trends in the incidence of and survival with heart failure. New England Journal of Medicine 2002 347 18 1397 1402 2-s2.0-0037206364 10.1056/NEJMoa020265 (Pubitemid 35239711)
7. Dunlay S. M., Redfield M. M., Weston S. A., Therneau T. M., Hall Long K., Shah N. D., Roger V. L., Hospitalizations after heart failure diagnosis. A community perspective. Journal of the American College of Cardiology 2009 54 18 1695 1702 2-s2.0-70349990206 10.1016/j.jacc.2009.08.019
8. Goldberg R. J., Ciampa J., Lessard D., Meyer T. E., Spencer F. A., Long-term survival after heart failure: a contemporary population-based perspective. Archives of Internal Medicine 2007 167 5 490 496 2-s2.0-33947203905 10.1001/archinte.167.5.490 (Pubitemid 46425662)
9. Ferrario C. M., Iyer S. N., Angiotensin-(1-7): a bioactive fragment of the renin-angiotensin system. Regulatory Peptides 1998 78 1-3 13 18 2-s2.0-0032583129 10.1016/S0167-0115(98)00134-7 (Pubitemid 28561512)
10. Ferrario C. M., Angiotensin-(1-7) and antihypertensive mechanisms. Journal of Nephrology 1998 11 6 278 283 2-s2.0-0032216598 (Pubitemid 29071216)
11. Santos R. A. S., Simoes e Silva A. C., Maric C., Silva D. M. R., Machado R. P., De Buhr I., Heringer-Walther S., Pinheiro S. V. B., Lopes M. T., Bader M., Mendes E. P., Lemos V. S., Campagnole-Santos M. J., Schultheiss H., Speth R., Walther T., Angiotensin-(1-7) is an endogenous ligand for the G protein-coupled receptor Mas. Proceedings of the National Academy of Sciences of the United States of America 2003 100 14 8258 8263 2-s2.0-0037478671 10.1073/pnas.1432869100 (Pubitemid 36842532)
12. Zisman L. S., Keller R. S., Weaver B., Lin Q., Speth R., Bristow M. R., Canver C. C., Increased angiotensin-(1-7)-forming activity in failing human heart ventricles: evidence for upregulation of the angiotensin-converting enzyme homologue ACE2. Circulation 2003 108 14 1707 1712 2-s2.0-0141988865 10.1161/01.CIR.0000094734.67990.99 (Pubitemid 37243658)
13. Campbell D. J., Zeitz C. J., Esler M. D., Horowitz J. D., Evidence against a major role for angiotensin converting enzyme-related carboxypeptidase (ACE2) in angiotensin peptide metabolism in the human coronary circulation. Journal of Hypertension 2004 22 10 1971 1976 2-s2.0-5044220674 10.1097/00004872-200410000-00020 (Pubitemid 39336680)
14. Keidar S., Kaplan M., Gamliel-Lazarovich A., ACE2 of the heart: from angiotensin I to angiotensin (1-7). Cardiovascular Research 2007 73 3 463 469 2-s2.0-33846256550 10.1016/j.cardiores.2006.09.006 (Pubitemid 46091776)
15. Ferrario C. M., Chappell M. C., Tallant E. A., Brosnihan K. B., Diz D. I., Counterregulatory actions of angiotensin-(1-7). Hypertension 1997 30 3 535 541 2-s2.0-0030810845 (Pubitemid 27444228)
16. Calò L. A., Schiavo S., Davis P. A., Pagnin E., Mormino P., D'Angelo A., Pessina A. C., ACE2 and angiotensin 1-7 are increased in a human model of cardiovascular hyporeactivity: pathophysiological implications. Journal of Nephrology 2010 23 4 472 477 2-s2.0-77955440123
17. Mercure C., Yogi A., Callera G. E., Aranha A. B., Bader M., Ferreira A. J., Santos R. A. S., Walther T., Touyz R. M., Reudelhuber T. L., Angiotensin(1-7) blunts hypertensive cardiac remodeling by a direct effect on the heart. Circulation Research 2008 103 11 1319 1326 2-s2.0-58149352445 10.1161/CIRCRESAHA.108.184911
18. Ueda S., Masumori-Maemoto S., Ashino K., Nagahara T., Gotoh E., Umemura S., Ishii M., Angiotensin-(1-7) attenuates vasoconstriction evoked by angiotensin II but not by noradrenaline in man. Hypertension 2000 35 4 998 1001 2-s2.0-0034028647 (Pubitemid 30303964)
19. Wilsdorf T., Gainer J. V., Murphey L. J., Vaughan D. E., Brown N. J., Angiotensin-(1-7) does not affect vasodilator or TPA responses to bradykinin in human forearm. Hypertension 2001 37 4 1136 1140 2-s2.0-0035050698 (Pubitemid 32304016)
20. Schiavone M. T., Santos R. A. S., Brosnihan K. B., Khosla M. C., Ferrario C. M., Release of vasopressin from the rat hypothalamo-neurohypophysial system by angiotensin-(1-7) heptapeptide. Proceedings of the National Academy of Sciences of the United States of America 1988 85 11 4095 4098 2-s2.0-0000254274
21. Santos R. A. S., Campagnole-Santos M. J., Andrade S. P., Angiotensin-(1-7): an update. Regulatory Peptides 2000 91 1-3 45 62 2-s2.0-0034725602 10.1016/S0167-0115(00)00138-5
22. Heitsch H., Brovkovych S., Malinski T., Wiemer G., Angiotensin-(1-7)- stimulated nitric oxide and superoxide release from endothelial cells. Hypertension 2001 37 1 72 76 2-s2.0-0035154879 (Pubitemid 32064242)
23. Li P., Chappell M. C., Ferrario C. M., Brosnihan K. B., Angiotensin-(1-7) augments bradykinin-induced vasodilation by competing with ACE and releasing nitric oxide. Hypertension 1997 29 1 394 400 2-s2.0-0031034312 (Pubitemid 27074074)
24. Trachte G. J., Meixner K., Ferrario C. M., Khosla M. C., Prostaglandin production in response to angiotensin-(1-7) in rabbit isolated vasa deferentia. Prostaglandins 1990 39 4 385 394 2-s2.0-0025344015 10.1016/0090-6980(90)90120-K (Pubitemid 20160009)
25. Jaiswal N., Tallant E. A., Diz D. I., Khosla M. C., Ferrario C. M., Subtype 2 angiotensin receptors mediate prostaglandin synthesis in human astrocytes. Hypertension 1991 17 6 1115 1120 2-s2.0-0026075497
26. Brosnihan K. B., Li P., Ferrario C. M., Angiotensin-(1-7) dilates canine coronary arteries through kinins and nitric oxide. Hypertension 1996 27 3 523 528 2-s2.0-0029926375 (Pubitemid 26086221)
27. Porsti I., Bara A. T., Busse R., Hecker M., Release of nitric oxide by angiotensin-(1-7) from porcine coronary endothelium: implications for a novel angiotensin receptor. British Journal of Pharmacology 1994 111 3 652 654 2-s2.0-0028275331 (Pubitemid 24151646)
28. Benter I. F., Ferrario C. M., Morris M., Diz D. I., Antihypertensive actions of angiotensin-(1-7) in spontaneously hypertensive rats. American Journal of Physiology 1995 269 1, part 2 H313 H319 2-s2.0-0029129342
29. Fernandes L., Fortes Z. B., Nigro D., Tostes R. C. A., Santos R. A. S., Catelli de Carvalho M. H., Potentiation of bradykinin by angiotensin-(1-7) on arterioles of spontaneously hypertensive rats studied in vivo. Hypertension 2001 37 2, part 2 703 709 2-s2.0-0035092904 (Pubitemid 32199053)
30. Paula R. D., Lima C. V., Khosla M. C., Santos R. A. S., Angiotensin-(1-7) potentiates the hypotensive effect of bradykinin in conscious rats. Hypertension 1995 26 6, part 2 1154 1159 2-s2.0-0028822339
31. Davie A. P., McMurray J. J. V., Effect of angiotensin-(1-7) and bradykinin in patients with heart failure treated with an ACE inhibitor. Hypertension 1999 34 3 457 460 2-s2.0-0032888404 (Pubitemid 29426763)
32. Batlle Perales M., Perez-Villa F., Lazaro A., Garcia-Pras E., Vallejos I., Roque M., Orus J., Roig E., The Ang(1-7) mas receptor expression is increased in myocardial tissue from heart failure patients that are in a highly active remodelling stage. European Journal of Heart Failure 2009 8 ii813
33. Ferrario C. M., Martell N., Yunis C., Flack J. M., Chappell M. C., Brosnihan K. B., Dean R. H., Fernandez A., Novikov S. V., Pinillas C., Luque M., Characterization of angeotensin-(1-7) in the urine of normal and essential hypertensive subjects. American Journal of Hypertension 1998 11 2 137 146 2-s2.0-0031594360 10.1016/S0895-7061(97)00400-7 (Pubitemid 28137604)
34. Roks A. J. M., Van Geel P. P., Pinto Y. M., Buikema H., Henning R. H., De Zeeuw D., Van Gilst W. H., Angiotensin-(1-7) is a modulator of the human renin-angiotensin system. Hypertension 1999 34 2 296 301 2-s2.0-0032820247 (Pubitemid 29409231)
35. Pan C., Wen C., Lin C., Interplay of angiotensin II and angiotensin(1-7) in the regulation of matrix metalloproteinases of human cardiocytes. Experimental Physiology 2008 93 5 599 612 2-s2.0-42649117475 10.1113/expphysiol.2007.041830 (Pubitemid 351595058)
36. Sampaio W. O., De Castro C. H., Santos R. A. S., Schiffrin E. L., Touyz R. M., Angiotensin-(1-7) counterregulates angiotensin II signaling in human endothelial cells. Hypertension 2007 50 6 1093 1098 2-s2.0-36448975192 10.1161/HYPERTENSIONAHA.106.084848 (Pubitemid 350172931)
37. Rajendran S., Chirkov Y. Y., Campbell D. J., Horowitz J. D., Angiotensin-(1-7) enhances anti-aggregatory effects of the nitric oxide donor sodium nitroprusside. Journal of Cardiovascular Pharmacology 2005 46 4 459 463 2-s2.0-26044445236 10.1097/01.fjc.0000176729.51819.a6 (Pubitemid 41407573)
38. Peltonen T., Näpänkangas J., Ohtonen P., Aro J., Peltonen J., Soini Y., Juvonen T., Satta J., Ruskoaho H., Taskinen P., (Pro)renin receptors and angiotensin converting enzyme 2/angiotensin-(1-7)/Mas receptor axis in human aortic valve stenosis. Atherosclerosis 2011 216 1 35 43 2-s2.0-79955541355 10.1016/j.atherosclerosis.2011.01.018
39. Christofi F., Wijetunge S., Sever P. S., Hughes A. D., Expression and function of the tissue-renin-angiotensin system in human vascular smooth muscle cells in culture. Cardiovascular Research 2010 87 S60
40. Sampaio W. O., Dos Santos R. A. S., Faria-Silva R., Da Mata Machado L. T., Schiffrin E. L., Touyz R. M., Angiotensin-(1-7) through receptor Mas mediates endothelial nitric oxide synthase activation via Akt-dependent pathways. Hypertension 2007 49 1 185 192 2-s2.0-33847018997 10.1161/01.HYP. 0000251865.35728.2f (Pubitemid 46360359)
41. Lin C., Pan C., Wen C., Yang T., Kuan T., Regulation of angiotensin converting enzyme II by angiotensin peptides in human cardiofibroblasts. Peptides 2010 31 7 1334 1340 2-s2.0-77952547547 10.1016/j.peptides.2010.03.026
42. Schindler C., Brosnihan K. B., Ferrario C. M., Bramlage P., Maywald U., Koch R., Oertel R., Kirch W., Comparison of inhibitory effects of irbesartan and atorvastatin treatment on the renin angiotensin system (RAS) in veins: a randomized double-blind crossover trial in healthy subjects. Journal of Clinical Pharmacology 2007 47 1 112 120 2-s2.0-33845783239 10.1177/0091270006294280 (Pubitemid 44974005)
43. Rajendran S., Chirkov Y. Y., Horowitz J. D., Potentiation of platelet responsiveness to nitric oxide by angiotensin-(1-7) is associated with suppression of superoxide release. Platelets 2007 18 2 158 164 2-s2.0-33947096470 10.1080/09537100600936158 (Pubitemid 46399002)
44. Ueda S., Masumori-Maemoto S., Wada A., Ishii M., Brosnihan K. B., Umemura S., Angiotensin(1-7) potentiates bradykinin-induced vasodilatation in man. Journal of Hypertension 2001 19 11 2001 2009 2-s2.0-0034755769 10.1097/00004872-200111000-00010 (Pubitemid 33035805)
45. Gironacci M. M., Adamo H. P., Corradi G., Santos R. A., Ortiz P., Carretero O. A., Angiotensin (1-7) induces mas receptor internalization. Hypertension 2011 58 2 176 181 2-s2.0-80051471498 10.1161/HYPERTENSIONAHA.111. 173344
46. Luque M., Martin P., Martell N., Fernandez C., Brosnihan K. B., Ferrario C. M., Effects of captopril related to increased levels of prostacyclin and angiotensin-(1-7) in essential hypertension. Journal of Hypertension 1996 14 6 799 805 2-s2.0-0029974215 10.1097/00004872-199606000-00017 (Pubitemid 26187416)
47. Hayashi N., Yamamoto K., Ohishi M., Tatara Y., Takeya Y., Shiota A., Oguro R., Iwamoto Y., Takeda M., Rakugi H., The counterregulating role of ACE2 and ACE2-mediated angiotensin 1-7 signaling against angiotensin II stimulation in vascular cells. Hypertension Research 2010 33 11 1182 1185 2-s2.0-78149308747 10.1038/hr.2010.147
48. Zisman L. S., Meixell G. E., Bristow M. R., Canver C. C., Angiotensin-(1-7) formation in the intact human heart: in vivo dependence on angiotensin II as substrate. Circulation 2003 108 14 1679 1681 2-s2.0-0141988867 10.1161/01.CIR.0000094733.61689.D4 (Pubitemid 37243653)
49. Gallagher P. E., Tallant E. A., Inhibition of human lung cancer cell growth by angiotensin-(1-7). Carcinogenesis 2004 25 11 2045 2052 2-s2.0-8844265279 10.1093/carcin/bgh236 (Pubitemid 39534840)
50. Pignone A., Del Rosso A., Brosnihan K. B., Perfetto F., Livi R., Fiori G., Guiducci S., Cinelli M., Rogai V., Tempestini A., Bartoli F., Generini S., Ferrario C. M., Cerinic M. M., Reduced circulating levels of angiotensin-(1-7) in systemic sclerosis: a new pathway in the dysregulation of endothelial-dependent vascular tone control. Annals of the Rheumatic Diseases 2007 66 10 1305 1310 2-s2.0-34848846815 10.1136/ard.2006.064493 (Pubitemid 47492472)
51. Silva A. C. S. E., Diniz J. S. S., Regueira Filho A., Santos R. A. S., The renin angiotensin system in childhood hypertension: selective increase of angiotensin-(1-7) in essential hypertension. Journal of Pediatrics 2004 145 1 93 98 2-s2.0-3242707890 10.1016/j.jpeds.2004.03.055 (Pubitemid 38962458)
52. Simões E Silva A. C., Diniz J. S. S., Pereira R. M., Pinheiro S. V. B., Santos R. A. S., Circulating renin angiotensin system in childhood chronic renal failure: marked increase of angiotensin-(1-7) in end-stage renal disease. Pediatric Research 2006 60 6 734 739 2-s2.0-33751254359 10.1203/01.pdr. 0000246100.14061.bc (Pubitemid 44789518)
53. Nickenig G., Geisen G., Vetter H., Sachinidis A., Characterization of angiotensin receptors on human skin fibroblasts. Journal of Molecular Medicine 1997 75 3 217 222 2-s2.0-0030938974 10.1007/s001090050106 (Pubitemid 27132684)
54. Anton L., Merrill D. C., Neves L. A. A., Brosnihan K. B., Angiotensin-(1-7) inhibits in vitro endothelial cell tube formation in human umbilical vein endothelial cells through the AT1-7 receptor. Endocrine 2007 32 2 212 218 2-s2.0-40349093102 10.1007/s12020-007-9022-1
55. Villalobos L., Romacho T., Cercas E., Palacios E., Sanchez Ferrer C., Peir C., The angiotensin-(1-7)/Mas receptor axis exhibits anti-inflammatory properties in human vascular smooth muscle cells. European Journal of Clinical Pharmacology 2010 66 S40
56. Montezano A. C., Yusuf H., Santos R. A., Castro C. H., Touyz R. M., Angiotensin 1-7 attenuates growth and inflammation induced by ET-1 in human endothelial cells-Crosstalk between mas and ETB receptors. Hypertension 2010 56 5 e144
57. Peltonen T., Napankangas J., Ohtonen P., Aro J., Peltonen J., Ruskoaho H., Taskinen P., Defining local renin-angiotensin system in human aortic valve stenosis: gene-expression of ACE2 and mas receptor in stenotic valves. Cardiology 2010 115 4 281 282
58. Zhiming Y., A study on effects of Ang II and Ang-(107) on cholesterol efflux in THP-1 human macrophages. Circulation 2010 122 2 e139 10.1161/CIR.0b013e318202056b
59. Vzquez-Bella M., Valleja S., Azcutia V., Romacho T., Cercas E., Palacios E., Rodrguez-Maas L., Novella S., Hermenegildo C., Walther T., Peir C., Snchez-Ferrer C. F., The role of the angiotensin-(1-7)/receptor Mas axis in endothelial dysfunction. Methods and Findings in Experimental and Clinical Pharmacology A 2009 31 supplement 6 140
60. Santos R. A. S., Brosnihan K. B., Jacobsen D. W., DiCorleto P. E., Ferrario C. M., Production of angiotensin-(1-7) by human vascular endothelium. Hypertension 1992 19 supplement 2 II56 II61 2-s2.0-0026513413
61. Hermenegildo C., Sobrino A., Monsalve E., Bueno C., Oviedo P. J., Peir C., Snchez-Ferrer C. F., Novella S., Angiotensin 1-7 mas receptor mediates nitric oxide production induced by estradiol in endothelial cells. European Journal of Clinical Pharmacology 2010 66 S40
62. Kono T., Taniguchi A., Imura H., Biological activities of angiotensin II-(1-6)-hexapeptide and angiotensin II-(1-7)-heptapeptide in man. Life Sciences 1986 38 16 1515 1519 2-s2.0-0022444188 (Pubitemid 16069406)
63. Sasaki S., Higashi Y., Nakagawa K., Matsuura H., Kajiyama G., Oshima T., Effects of angiotensin-(1-7) on forearm circulation in normotensive subjects and patients with essential hypertension. Hypertension 2001 38 1 90 94 2-s2.0-0035569025 (Pubitemid 34224777)
64. Calò L. A., Schiavo S., Davis P. A., Pagnin E., Mormino P., D'Angelo A., Pessina A. C., ACE2 and angiotensin 1-7 are increased in a human model of cardiovascular hyporeactivity: pathophysiological implications. Journal of Nephrology 2010 23 4 472 477 2-s2.0-77955440123
65. Benjamin N., Cockcroft J. R., Collier J. G., Dollery C. T., Ritter J. M., Webb D. J., Local inhibition of converting enzyme and vascular responses to angiotensin and bradykinin in the human forearm. Journal of Physiology 1989 412 543 555 2-s2.0-0024409095 (Pubitemid 19134497)
66. Von Bohlen und Halbach O., Walther T., Bader M., Albrecht D., Genetic deletion of angiotensin AT2 receptor leads to increased cell numbers in different brain structures of mice. Regulatory Peptides 2001 99 2-3 209 216 2-s2.0-0035876746 10.1016/S0167-0115(01)00258-0 (Pubitemid 32522549)
67. Goulter A. B., Goddard M. J., Allen J. C., Clark K. L., ACE2 gene expression is up-regulated in the human failing heart. BMC Medicine 2004 2 19 2-s2.0-4243105120 10.1186/1741-7015-2-19 (Pubitemid 39111859)
68. Li Y. Y., Feldman A. M., Sun Y., McTiernan C. F., Differential expression of tissue inhibitors of metalloproteinases in the failing human heart. Circulation 1998 98 17 1728 1734 2-s2.0-0001751017 (Pubitemid 28492492)
69. Spinale F. G., Coker M. L., Heung L. J., Bond B. R., Gunasinghe H. R., Etoh T., Goldberg A. T., Zellner J. L., Crumbley A. J., A matrix metalloproteinase induction/activation system exists in the human left ventricular myocardium and is upregulated in heart failure. Circulation 2000 102 16 1944 1949 2-s2.0-0034680366
70. Schwartzkopff B., Fassbach M., Pelzer B., Brehm M., Strauer B. E., Elevated serum markers of collagen degradation in patients with mild to moderate dilated cardiomyopathy. European Journal of Heart Failure 2002 4 4 439 444 2-s2.0-0036672897 10.1016/S1388-9842(02)00092-2 (Pubitemid 36564961)
71. Yamamoto K., Chappell M. C., Brosnihan K. B., Ferrario C. M., In vivo metabolism of angiotensin I by neutral endopeptidase (EC 3.4.24.11) in spontaneously hypertensive rats. Hypertension 1992 19 supplement 6 692 696 2-s2.0-0026605307
72. Cleland J. G. F., Daubert J., Erdmann E., Freemantle N., Gras D., Kappenberger L., Tavazzi L., The effect of cardiac resynchronization on morbidity and mortality in heart failure. New England Journal of Medicine 2005 352 15 1539 1549 2-s2.0-16844364826 10.1056/NEJMoa050496 (Pubitemid 40517094)
73. Peiró C., Vallejo S., Gembardt F., Azcutia V., Heringer-Walther S., Rodríguez-Mañas L., Schultheiss H., Sánchez-Ferrer C. F., Walther T., Endothelial dysfunction through genetic deletion or inhibition of the G protein-coupled receptor Mas: a new target to improve endothelial function. Journal of Hypertension 2007 25 12 2421 2425 2-s2.0-35848966134 10.1097/HJH.0b013e3282f0143c (Pubitemid 350060381)
74. Wang Y., Qian C., Roks A. J. M., Westermann D., Schumacher S., Escher F., Schoemaker R. G., Reudelhuber T. L., Van Gilst W. H., Schultheiss H., Tschöpe C., Walther T., Circulating rather than cardiac angiotensin-(1-7) stimulates cardioprotection after myocardial infarction. Circulation 2010 3 2 286 293 2-s2.0-77951890433 10.1161/CIRCHEARTFAILURE.109.905968
75. Ebermann L., Spillmann F., Sidiropoulos M., Escher F., Heringer-Walther S., Schultheiss H., Tschöpe C., Walther T., The angiotensin-(1-7) receptor agonist AVE0991 is cardioprotective in diabetic rats. European Journal of Pharmacology 2008 590 1-3 276 280 2-s2.0-48049120612 10.1016/j.ejphar.2008.05. 024
76. Heringer-Walther S., Eckert K., Schumacher S., Uharek L., Wulf-Goldenberg A., Gembardt F., Fichtner I., Schultheiss H., Rodgers K., Walther T., Angiotensin-(1-7) stimulates hematopoietic progenitor cells in vitro and in vivo. Haematologica 2009 94 6 857 860 2-s2.0-66749124113 10.3324/haematol.2008. 000034
77. Petty W. J., Miller A. A., McCoy T. P., Gallagher P. E., Tallant E. A., Torti F. M., Phase I and pharmacokinetic study of angiotensin-(1-7), an endogenous antiangiogenic hormone. Clinical Cancer Research 2009 15 23 7398 7404 2-s2.0-73149102795 10.1158/1078-0432.CCR-09-1957
78. Rodgers K. E., Oliver J., DiZerega G. S., Phase I/II dose escalation study of angiotensin 1-7 [A(1-7)] administered before and after chemotherapy in patients with newly diagnosed breast cancer. Cancer Chemotherapy and Pharmacology 2006 57 5 559 568 2-s2.0-32544458020 10.1007/s00280-005-0078-4 (Pubitemid 43237839)
79. Grobe J. L., Mecca A. P., Mao H., Katovich M. J., Chronic angiotensin-(1-7) prevents cardiac fibrosis in DOCA-salt model of hypertension. American Journal of Physiology 2006 290 6 H2417 H2423 2-s2.0-33744910056 10.1152/ajpheart.01170.2005 (Pubitemid 43846070)
80. Ferreira A. J., Shenoy V., Qi Y., Fraga-Silva R. A., Santos R. A. S., Katovich M. J., Raizada M. K., Angiotensin-converting enzyme 2 activation protects against hypertension-induced cardiac fibrosis involving extracellular signal-regulated kinases. Experimental Physiology 2011 96 3 287 294 2-s2.0-79951509062 10.1113/expphysiol.2010.055277
81. Schindler C., Bramlage P., Kirch W., Ferrario C. M., Role of the vasodilator peptide angiotensin-(1-7) in cardiovascular drug therapy. Vascular Health and Risk Management 2007 3 1 125 137 2-s2.0-34249848335 (Pubitemid 46860722)